Proton Beam Radiation Therapy for Oropharyngeal Squamous Cell Carcinoma

Purpose To discuss the role of proton beam therapy (PBT) in the treatment of patients with oropharyngeal squamous cell carcinoma (OPSCC). Materials and Methods A review of the pertinent literature. Results Proton beam therapy likely results in reduced acute and late toxicity as compared with intensity-modulated radiation therapy (IMRT). The extent of the reduced toxicity, which may be modest, depends on the endpoint and technical factors such as pencil beam versus passive scattered PBT and adaptive replanning. The disease control rates after PBT are likely similar to those after IMRT. Conclusion Proton beam therapy is an attractive option to treat patients with OPSCC. Whether it becomes widely available depends on access.

[1]  A. Eisbruch,et al.  Proton Therapy for Squamous Cell Carcinoma of the Head and Neck: Early Clinical Experience and Current Challenges , 2022, Cancers.

[2]  N. Lee,et al.  Evaluation of Substantial Reduction in Elective Radiotherapy Dose and Field in Patients With Human Papillomavirus-Associated Oropharyngeal Carcinoma Treated With Definitive Chemoradiotherapy. , 2022, JAMA oncology.

[3]  P. Bondiau,et al.  Optimizing oropharyngeal cancer management by using proton beam therapy: trends of cost-effectiveness , 2021, BMC Cancer.

[4]  A. Garden,et al.  Determinants of patient‐reported xerostomia among long‐term oropharyngeal cancer survivors , 2021, Cancer.

[5]  W. Mendenhall,et al.  Insurance Approval for Definitive Proton Therapy for Prostate Cancer , 2021, International journal of particle therapy.

[6]  A. Garden,et al.  Proton Therapy for HPV-Associated Oropharyngeal Cancers of the Head and Neck: a De-Intensification Strategy , 2021, Current Treatment Options in Oncology.

[7]  A. Garden,et al.  Activity-Based Costing of Intensity-Modulated Proton versus Photon Therapy for Oropharyngeal Cancer , 2021, International journal of particle therapy.

[8]  A. Garden,et al.  Work Outcomes after Intensity-Modulated Proton Therapy (IMPT) versus Intensity-Modulated Photon Therapy (IMRT) for Oropharyngeal Cancer , 2021, International journal of particle therapy.

[9]  Steven J. Frank,et al.  Cost-Effectiveness Models of Proton Therapy for Head and Neck: Evaluating Quality and Methods to Date , 2021, International journal of particle therapy.

[10]  A. Garden,et al.  Patient-Reported Outcomes after Intensity-Modulated Proton Therapy for Oropharynx Cancer , 2021, International journal of particle therapy.

[11]  A. Garden,et al.  Intensity-modulated proton therapy for oropharyngeal cancer reduces rates of late xerostomia. , 2021, Radiotherapy and oncology : journal of the European Society for Therapeutic Radiology and Oncology.

[12]  J. Noh,et al.  Early Clinical Outcomes of Intensity Modulated Radiation Therapy/Intensity Modulated Proton Therapy Combination in Comparison with Intensity Modulated Radiation Therapy Alone in Oropharynx Cancer Patients , 2021, Cancers.

[13]  S. Kalnicki,et al.  Individualized quality of life benefit and cost-effectiveness estimates of proton therapy for patients with oropharyngeal cancer , 2021, Radiation oncology.

[14]  A. van der Schaaf,et al.  Development of advanced preselection tools to reduce redundant plan comparisons in model-based selection of head and neck cancer patients for proton therapy. , 2020, Radiotherapy and oncology : journal of the European Society for Therapeutic Radiology and Oncology.

[15]  D. Mundy,et al.  Evaluation of replanning in intensity-modulated proton therapy for oropharyngeal cancer: Factors influencing plan robustness. , 2020, Medical dosimetry : official journal of the American Association of Medical Dosimetrists.

[16]  D. Chang,et al.  Second cancer risk after primary cancer treatment with three‐dimensional conformal, intensity‐modulated, or proton beam radiation therapy , 2020, Cancer.

[17]  A. Lin,et al.  Predicted Secondary Malignancies following Proton versus Photon Radiation for Oropharyngeal Cancers , 2020, International journal of particle therapy.

[18]  A. Garden,et al.  Prospective longitudinal patient-reported outcomes of swallowing following intensity modulated proton therapy for oropharyngeal cancer. , 2020, Radiotherapy and oncology : journal of the European Society for Therapeutic Radiology and Oncology.

[19]  Andrew G. Lee,et al.  Clinical Outcomes and Toxicities in Oropharyngeal Cancer (OPC) Patients Treated with Proton Therapy: A Single Institutional Experience , 2020 .

[20]  Jeffrey L. Anderson,et al.  Comparative analysis of acute toxicities and patient reported outcomes between intensity-modulated proton therapy (IMPT) and volumetric modulated arc therapy (VMAT) for the treatment of oropharyngeal cancer. , 2020, Radiotherapy and oncology : journal of the European Society for Therapeutic Radiology and Oncology.

[21]  N. Iles,et al.  TORPEdO - A Phase III Trial of Intensity-modulated Proton Beam Therapy Versus Intensity-modulated Radiotherapy for Multi-toxicity Reduction in Oropharyngeal Cancer. , 2020, Clinical oncology (Royal College of Radiologists (Great Britain)).

[22]  J. Langendijk,et al.  Reduced radiation-induced toxicity by using proton therapy for the treatment of oropharyngeal cancer. , 2020, The British journal of radiology.

[23]  G. Laramore,et al.  Proton Therapy for Locally Advanced Oropharyngeal Cancer: Initial Clinical Experience at the University of Washington. , 2019, International journal of particle therapy.

[24]  C. Glastonbury,et al.  Advances in Diagnosis and Multidisciplinary Management of Oropharyngeal Squamous Cell Carcinoma: State of the Art. , 2019, Radiographics : a review publication of the Radiological Society of North America, Inc.

[25]  W. Mendenhall,et al.  Insurance Coverage for Adjuvant Proton Therapy in the Definitive Treatment of Breast Cancer. , 2019, International journal of particle therapy.

[26]  S. Kalnicki,et al.  A Quantitative Clinical Decision-Support Strategy Identifying Which Patients With Oropharyngeal Head and Neck Cancer May Benefit the Most From Proton Radiation Therapy. , 2019, International journal of radiation oncology, biology, physics.

[27]  N. Lester-Coll,et al.  Modeling the Potential Benefits of Proton Therapy for Patients With Oropharyngeal Head and Neck Cancer. , 2019, International journal of radiation oncology, biology, physics.

[28]  H. Kooy,et al.  Impact of setup and range uncertainties on TCP and NTCP following VMAT or IMPT of oropharyngeal cancer patients , 2019, Physics in medicine and biology.

[29]  J. Langendijk,et al.  First experience with model-based selection of head and neck cancer patients for proton therapy. , 2019, Radiotherapy and oncology : journal of the European Society for Therapeutic Radiology and Oncology.

[30]  Reid F Thompson,et al.  Quality of Life of Postoperative Photon versus Proton Radiation Therapy for Oropharynx Cancer , 2018, International journal of particle therapy.

[31]  Nhat-Long Pham,et al.  Cost-Effectiveness Analysis of Intensity Modulated Radiation Therapy Versus Proton Therapy for Oropharyngeal Squamous Cell Carcinoma. , 2018, International journal of radiation oncology, biology, physics.

[32]  D. Hayes,et al.  Mature results of a prospective study of deintensified chemoradiotherapy for low‐risk human papillomavirus‐associated oropharyngeal squamous cell carcinoma , 2018, Cancer.

[33]  A. Garden,et al.  Comparing Intensity-Modulated Proton Therapy With Intensity-Modulated Photon Therapy for Oropharyngeal Cancer: The Journey From Clinical Trial Concept to Activation. , 2018, Seminars in radiation oncology.

[34]  Radhe Mohan,et al.  Intensity-Modulated Proton Therapy Adaptive Planning for Patients with Oropharyngeal Cancer. , 2017, International journal of particle therapy.

[35]  Kristin Stützer,et al.  Superiority in Robustness of Multifield Optimization Over Single-Field Optimization for Pencil-Beam Proton Therapy for Oropharynx Carcinoma: An Enhanced Robustness Analysis. , 2017, International journal of radiation oncology, biology, physics.

[36]  W. Mendenhall,et al.  Rapid Radiation Therapy for Advanced Cancer of the Head and Neck #336. , 2017, Journal of palliative medicine.

[37]  A. Garden,et al.  Intensity-modulated proton therapy and osteoradionecrosis in oropharyngeal cancer. , 2017, Radiotherapy and oncology : journal of the European Society for Therapeutic Radiology and Oncology.

[38]  Nadeem Riaz,et al.  Proton therapy for head and neck cancer: expanding the therapeutic window. , 2017, The Lancet. Oncology.

[39]  A. Garden,et al.  Dosimetric advantages of intensity-modulated proton therapy for oropharyngeal cancer compared with intensity-modulated radiation: A case-matched control analysis. , 2016, Medical dosimetry : official journal of the American Association of Medical Dosimetrists.

[40]  W. Mendenhall,et al.  Ipsilateral radiotherapy for squamous cell carcinoma of the tonsil , 2016, European Archives of Oto-Rhino-Laryngology.

[41]  Steven J Frank,et al.  Intensity-Modulated Proton Therapy ( IMPT ) versus Intensity-Modulated Photon Radiotherapy ( IMRT ) for Oropharyngeal Cancer : First Comparative Results of Patient-Reported Outcomes , 2016 .

[42]  Steven J Frank,et al.  Intensity-modulated proton beam therapy (IMPT) versus intensity-modulated photon therapy (IMRT) for patients with oropharynx cancer - A case matched analysis. , 2016, Radiotherapy and oncology : journal of the European Society for Therapeutic Radiology and Oncology.

[43]  R. Mohan,et al.  Clinical Outcomes and Patterns of Disease Recurrence After Intensity Modulated Proton Therapy for Oropharyngeal Squamous Carcinoma. , 2016, International journal of radiation oncology, biology, physics.

[44]  Johannes A Langendijk,et al.  Using a reduced spot size for intensity-modulated proton therapy potentially improves salivary gland-sparing in oropharyngeal cancer. , 2012, International journal of radiation oncology, biology, physics.

[45]  Johannes A Langendijk,et al.  Potential benefits of scanned intensity-modulated proton therapy versus advanced photon therapy with regard to sparing of the salivary glands in oropharyngeal cancer. , 2011, International journal of radiation oncology, biology, physics.

[46]  Jonathan G. Li,et al.  Intensity‐modulated radiotherapy for oropharyngeal squamous cell carcinoma 1 , 2010, The Laryngoscope.

[47]  K. Ang,et al.  Human papillomavirus and survival of patients with oropharyngeal cancer. , 2010, The New England journal of medicine.

[48]  D. Moher,et al.  Preferred reporting items for systematic reviews and meta-analyses: the PRISMA statement , 2009, BMJ.

[49]  D. Moher,et al.  Preferred Reporting Items for Systematic Reviews and Meta-Analyses: The PRISMA Statement , 2009, BMJ : British Medical Journal.

[50]  H. Christiansen,et al.  Long-term follow-up after transoral laser microsurgery and adjuvant radiotherapy for advanced recurrent squamous cell carcinoma of the head and neck. , 2006, International journal of radiation oncology, biology, physics.

[51]  Daniel W. Miller,et al.  Proton radiation for treatment of cancer of the oropharynx: early experience at Loma Linda University Medical Center using a concomitant boost technique. , 2005, International journal of radiation oncology, biology, physics.

[52]  Gwyn McClelland Survivors , 1891, The Hospital.